Skip to content

Clinical trials

Myelodysplastic Syndromes trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Not applicable Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20022
20033
20044
20055
20062
20072
20089
20093
20101
20123
20133
20143
20153
20162
20174
20181
20193
20201
20216
20222
20232
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated16
Recruiting11
Active, not recruiting3
Unknown status2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Masonic Cancer Center, University of Minnesota5
Dana-Farber Cancer Institute4
Fred Hutchinson Cancer Center4
Memorial Sloan Kettering Cancer Center4
Stanford University4
City of Hope Medical Center3
National Heart, Lung, and Blood Institute (NHLBI)3
University of Miami3
University of Rochester3
Washington University School of Medicine3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes82
Leukemia, Myeloid, Acute54
Precursor Cell Lymphoblastic Leukemia-Lymphoma44
Leukemia42
Lymphoma, Non-Hodgkin38
Multiple Myeloma35
Hodgkin Disease33
Lymphoma30
Leukemia, Lymphocytic, Chronic, B-Cell29
Myeloproliferative Disorders27

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.